MS risk sharing scheme - counter argument, Richard J Lilford

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

MS risk sharing scheme - counter argument, Richard J Lilford

Postby MSUK » Tue Jun 08, 2010 8:41 am

Image

MS drug risk sharing scheme could not yield valid data after only two years follow up.

As chair of the Scientific Advisory Committee (SAG) of the Multiple Sclerosis Risk Sharing Scheme I strongly reject the suggestion that our advice is based on any considerations other than scientific rigour.

Members of DH and of the 4 companies attend meetings with observer status only. Final decisions relating to the scheme, e.g. on whether to apply price adjustments at any point, are taken between the parties to the scheme informed by advice from my committee. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1893
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service